ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 56 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q1 2021. The put-call ratio across all filers is 1.20 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $12,000 | -58.6% | 56,257 | 0.0% | 0.00% | – |
| Q2 2022 | $29,000 | -12.1% | 56,257 | 0.0% | 0.00% | – |
| Q1 2022 | $33,000 | -5.7% | 56,257 | 0.0% | 0.00% | – |
| Q4 2021 | $35,000 | -36.4% | 56,257 | 0.0% | 0.00% | – |
| Q3 2021 | $55,000 | -11.3% | 56,257 | 0.0% | 0.00% | – |
| Q2 2021 | $62,000 | +17.0% | 56,257 | 0.0% | 0.00% | – |
| Q1 2021 | $53,000 | +488.9% | 56,257 | +240.6% | 0.00% | – |
| Q4 2020 | $9,000 | -30.8% | 16,516 | 0.0% | 0.00% | – |
| Q3 2020 | $13,000 | +44.4% | 16,516 | 0.0% | 0.00% | – |
| Q2 2020 | $9,000 | +50.0% | 16,516 | 0.0% | 0.00% | – |
| Q1 2020 | $6,000 | -50.0% | 16,516 | 0.0% | 0.00% | – |
| Q4 2019 | $12,000 | 0.0% | 16,516 | 0.0% | 0.00% | – |
| Q3 2019 | $12,000 | -45.5% | 16,516 | 0.0% | 0.00% | – |
| Q2 2019 | $22,000 | -37.1% | 16,516 | 0.0% | 0.00% | – |
| Q1 2019 | $35,000 | – | 16,516 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BARD ASSOCIATES INC | 124,300 | $87,000 | 0.04% |
| Hayden Royal, LLC | 16,000 | $12,272,000 | 0.01% |
| Global Strategic Investment Solutions, LLC | 23,000 | $16,000 | 0.01% |
| Founders Capital Management | 8,000 | $6,000 | 0.01% |
| Cable Hill Partners, LLC | 20,000 | $14,000 | 0.00% |
| Jacobi Capital Management LLC | 25,000 | $18,000 | 0.00% |
| Stonebridge Capital Advisors LLC | 22,000 | $15,000 | 0.00% |
| B. Riley Wealth Advisors, Inc. | 37,520 | $27,000 | 0.00% |
| Firestone Capital Management | 5,200 | $4,000 | 0.00% |
| MGO ONE SEVEN LLC | 10,615 | $7,000 | 0.00% |